HMGB1 and metabolic dysfunction-associated steatotic liver disease: This observation was substantiated using a large cohort study of pediatric patients with biopsy-confirmed NAFLD, which showed higher levels of circulating HMGB1 in children with NAFLD than in obese-only controls.